These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 31337360)

  • 1. Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with Conbercept in China.
    Liu S; Wang D; Chen F; Zhang X
    BMC Ophthalmol; 2019 Jul; 19(1):157. PubMed ID: 31337360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment response to Conbercept of different types of diabetic macular edema classified based on optical coherence tomography].
    Zhang Y; Yao J; Quan Y; Wang J; Xing Y; Zhou A
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1501-1508. PubMed ID: 34755665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of retinal layer changes with vision gain in diabetic macular edema during conbercept treatment.
    Xu Y; Qu Y; Suo Y; Gao J; Chen X; Liu K; Xu X
    BMC Ophthalmol; 2019 May; 19(1):123. PubMed ID: 31151389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study.
    Xu Y; Rong A; Xu W; Niu Y; Wang Z
    BMC Ophthalmol; 2017 Aug; 17(1):158. PubMed ID: 28841827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CORRELATION OF OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI WITH VISUAL OUTCOMES IN DIFFERENT PATTERNS OF DIABETIC MACULAR EDEMA.
    Kang JW; Chung H; Chan Kim H
    Retina; 2016 Sep; 36(9):1630-9. PubMed ID: 26900741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-Year Outcome of Conbercept Therapy for Diabetic Macular Edema.
    Li F; Zhang L; Wang Y; Xu W; Jiao W; Ma A; Zhao B
    Curr Eye Res; 2018 Feb; 43(2):218-223. PubMed ID: 29265939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.
    Tang F; Qin X; Lu J; Song P; Li M; Ma X
    Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year outcomes of novel VEGF decoy receptor therapy with intravitreal conbercept in diabetic retinopathy-induced macular edema.
    Zhou Q; Guo C; You A; Wang D; Wang W; Zhang X
    Mol Vis; 2019; 25():636-644. PubMed ID: 31700228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
    Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
    Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of inner and outer retinal thickness in patients receiving intravitreal ranibizumab injections for diabetic macular edema.
    Dursun A; Ozec AV; Kirboga K; Dursun FG; Toker MI; Erdogan H; Arici MK
    Eur J Ophthalmol; 2016; 26(1):48-53. PubMed ID: 26220809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography biomarkers DROL, PROS, SND, hyperreflective walls of foveal cystoid spaces as predictors of central macular thickness and visual acuity in diabetic macular edema treated with intravitreal ranibizumab.
    Sardana A; Singh K; Singh A; Singh VK
    Indian J Ophthalmol; 2024 May; 72(5):722-727. PubMed ID: 38648434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHANGES IN CENTRAL CHOROIDAL THICKNESS AFTER TREATMENT OF DIABETIC MACULAR EDEMA WITH INTRAVITREAL BEVACIZUMAB CORRELATION WITH CENTRAL MACULAR THICKNESS AND BEST-CORRECTED VISUAL ACUITY.
    Nourinia R; Ahmadieh H; Nekoei E; Malekifar P; Tofighi Z
    Retina; 2018 May; 38(5):970-975. PubMed ID: 28426622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macular dynamics and visual acuity prognosis in retinal vein occlusions - ways to connect.
    Dărăbuș DM; Pac CP; Roşca C; Munteanu M
    Rom J Ophthalmol; 2023; 67(3):312-324. PubMed ID: 37876516
    [No Abstract]   [Full Text] [Related]  

  • 14. HYPERREFLECTIVE RETINAL SPOTS AND VISUAL FUNCTION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN CENTER-INVOLVING DIABETIC MACULAR EDEMA.
    Vujosevic S; Berton M; Bini S; Casciano M; Cavarzeran F; Midena E
    Retina; 2016 Jul; 36(7):1298-308. PubMed ID: 26689274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in choroidal thickness after anti-vascular endothelial growth factor treatment of diabetic macular edema, real-life data, 2-year results.
    Savur F; Kaldırım H; Atalay K; Korkmaz Ş
    Cutan Ocul Toxicol; 2021 Dec; 40(4):326-331. PubMed ID: 34275395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional analysis of morphologic changes and visual outcomes in diabetic macular edema.
    Lee H; Kang KE; Chung H; Kim HC
    Jpn J Ophthalmol; 2019 May; 63(3):234-242. PubMed ID: 30783942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavior of SD-OCT-detected hyperreflective foci in the retina of anti-VEGF-treated patients with diabetic macular edema.
    Framme C; Schweizer P; Imesch M; Wolf S; Wolf-Schnurrbusch U
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5814-8. PubMed ID: 22836760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and anatomic results of up to 24 months aflibercept treatment for diabetic macular edema in real-life setting.
    Tsapardoni FN; Makri OE; Lagogiannis AP; Tsekouras IK; Chairas N; Pallikari A; Pagoulatos DD; Georgakopoulos CD
    Hell J Nucl Med; 2019; 22 Suppl 2():47-54. PubMed ID: 31802045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fellow eye effect of unilateral intravitreal conbercept injections in eyes with diabetic macular edema.
    Di Y; Li Z; Ye J; Li L; Li B; Yu R
    Acta Diabetol; 2020 Aug; 57(8):1001-1007. PubMed ID: 32215730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Conbercept with Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Li F; Sun M; Guo J; Ma A; Zhao B
    Curr Eye Res; 2017 Aug; 42(8):1174-1178. PubMed ID: 28441077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.